Cyclacel Pharmaceuticals, Inc.'s David Glover to Present at New York Academy of Sciences Symposium

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today that its chief scientist, Professor David Glover, will participate in a Symposium on "Pharmacologic Regulation of DNA Damage Checkpoints to Treat Cancer." The event will take place on Thursday, March 13, 2008 from 1:00 pm to 5:30 pm Eastern time at The New York Academy of Sciences (NYAS), located at 7 World Trade Center, 250 Greenwich Street, New York, NY.